VWM
PAVM icon

Vigilare Wealth Management’s PAVmed PAVM Stock Holding History

Vigilare Wealth Management’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-30
Closed -$33K – 156
2021
Q4 		$33K Sell
30
-114
-79% -$248K 0.02% 176
2021
Q3 		$555K Sell
144
-55
-28% -$173K 0.34% 79
2021
Q2 		$574K Sell
199
-28
-12% -$66.1K 0.35% 81
2021
Q1 		$453K Sell
227
-188
-45% -$283K 0.32% 87
2020
Q4 		$396K Buy
415
+68
+20% +$58.2K 0.38% 61
2020
Q3 		$278K Buy
347
+79
+29% +$70.3K 0.29% 84
2020
Q2 		$255K Buy
268
+93
+53% +$93K 0.26% 83
2020
Q1 		$156K Buy
175
+153
+695% +$125K 0.19% 108
2019
Q4 		$15K Buy
+22
New +$9.16K 0.01% 149

Other funds holding PAVM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vigilare Wealth Management's PAVM Position: Q1 2022 in Review

Vigilare Wealth Management sold out of PAVmed (PAVM) in Q1 2022, closing a stake of 30 shares — an estimated $33K sold.

Vigilare Wealth Management first reported a position in PAVM in Q4 2019 and held it in 9 quarters. The position peaked at $574K in Q2 2021. 94 funds tracked by Wall St. Rank hold PAVM as of Q1 2022.

  • Vigilare Wealth Management reported no remaining PAVmed position as of Q1 2022 after selling out during the quarter.
  • Vigilare Wealth Management sold 30 PAVmed shares in Q1 2022, an estimated $33K.
  • Vigilare Wealth Management first reported a position in PAVmed in Q4 2019 and held it in 9 quarters.
  • Vigilare Wealth Management's PAVmed position peaked at $574K in Q2 2021.
  • 94 funds tracked by Wall St. Rank held PAVmed as of Q1 2022.

Based on Vigilare Wealth Management's 13F filing for Q1 2022, filed 6 Apr 2022.